LATEST ARTICLES

Australian Kazia Therapeutics Presents ‘Trial in Progress’ Data for Glioblastoma Study

Results for GDC-0084, an investigational drug being being developed by Australian- based and oncology-focused Kazia Therapeutics and currently in human trials for the treatment of patients with glioblastoma, the...

Interim Phase II Results of DNX-2401 + Pembrolizumab for Glioblastoma Shows Remarkable Results

Preliminary results from the CAPTIVE / KEYNOTE-192 study (NCT02798406) dose escalation study evaluating a single intratumoral injection of DNX-2401 (tasadenoturev; DNAtrix) followed by standard dosing with pembrolizumab (Keytruda®; Merck...

Otis Brawley Discusses Life After Leaving the American Cancer Society

When Otis W. Brawley, MD — who had served as the face of the American Cancer Society (ACS) for the past 11 years—resigned earlier this month as the organization’s...

Scientists, Physicians and Patients Collaborate to Improve Treatment of EGFR-Positive Lung Cancer

The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology and EGFR Resisters have announced the launch of a new study to create a novel bank of patient derived xenograft...

Isofol Initiates Pivotal Phase III Clinical Trial of Arfolitixorin for Metastatic Colorectal Cancer

Sweden-based Isofol Medical has initiated their pivotal Phase III clinical trial, called the ISO-CC-007 study, for the treatment of first-line (initial) metastatic colorectal cancer (mCRC). Arfolitixorin is a new drug...

Pancreatic Cancer Risk in Adulthood Affected by Weight During Adolescence

Adolescent obesity may increase the risk of pancreatic cancer later in life with up to a four-fold increased risk. This is the conclusion of a study published early online in...